SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kwality Pharmaceutical gets approval for manufacturing and sale of PEGylated-Asparaginase

26 Nov 2024 Evaluate

Kwality Pharmaceutical (KPL) has successfully received domestic and export product approvals for the manufacturing and sale of its biological product, PEGylated-Asparaginase. This significant milestone underscores the company’s commitment to delivering high-quality therapeutic solutions and marks an important step forward, as it is its first product from the biologics portfolio to be commercialized in both domestic and export markets.

L-Asparaginase is an E. coli-derived enzyme primarily used in the treatment of acute lymphoblastic leukemia (ALL). The PEGylation process enhances the stability of the molecule and reduces the risk of allergic reactions, thereby improving patient outcomes and treatment efficacy.

Furthermore, Kwality Pharmaceutical is actively engaged in discussions with leading domestic B2B companies to offer PEGylated-Asparaginase on a CDMO (Contract Development and Manufacturing Organization) basis. These collaborations aim to leverage its manufacturing expertise, ensuring wider availability of this critical therapy. This approach not only strengthens local partnerships but also enhances patient access across various regions. 

Kwality Pharmaceuticals (formerly Kwality Pharmaceuticals) is a pharmaceutical formation company.


Kwality Pharma Share Price

1583.75 -80.55 (-4.84%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×